Weinbergerová B, Čerňan M, Kabut T, Semerád L, Podstavková N, Szotkowski T, Ježíšková I, Mayer J. Gemtuzumab ozogamicin plus midostaurin in conjunction with standard intensive therapy for <i>FLT3</i&gt;- mutated acute myeloid leukemia patients – Czech center experience. Haematologica 2023;108(10):2826-2829; https://doi.org/10.3324/haematol.2022.282263.